<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2010-06-24 18:55:00Medicine Health Microbicides for sexually transmitted diseases HIV Clinical trial Antiretroviral drug Sexually transmitted disease CAPRISA 004 Vaginal microbicide Microbicides Microbiology Sexually transmitted diseases and infections |
Add to Reading List |
Microbicides Research & Development | October 26, 2007 Starpharma Pty Ltd Baker Building 75 Commercial Road Melbourne VIC 3004 AUSTRALIADocID: 1fIqv - View Document |
| A TRAVEL LING E XH I B IT Featuring In Her Mother’s Shoes, a story and photo essay by The Seattle Times It is our hope that thisDocID: 1fzPE - View Document |
| What is CAPRISA 004? CAPRISA 004 was a phase IIb, two-arm, double-blind, randomised, placebo-controlled trial designed to assess the safety and effectiveness of the vaginal microbicide candidate 1% tenofovir gel for theDocID: 1bY73 - View Document |
| Global Campaign for Microbicides, www.global-campaign.org 5. What to Do About Male Partners? SDocID: 1aCH6 - View Document |
| Microbicides Research & DevelopmentDocID: 1ayCz - View Document |